Hilo App
View blood pressure trends, personalized insights and doctor-ready reports
Company profile
Company profile
Hilo is a subscription-based remote patient monitoring company that provides continuous, cuffless blood pressure monitoring through a clinically validated wearable system. The company's solution combines three core components: the Hilo Band (a medical-grade wearable for continuous monitoring), the Hilo Cuff (for periodic calibration), and the Hilo App (for insights and reporting). Unlike traditional blood pressure cuffs that capture single moments, Hilo automatically measures blood pressure approximately 25 times per day throughout day and night, revealing patterns linked to sleep, stress, movement, and recovery. The technology is powered by Aktiia's platform, built on over 20 years of research and used by more than 120,000 people worldwide. Hilo uses photoplethysmography (PPG) and pulse wave analysis (PWA) to estimate blood pressure from optical wrist data. The system is CE-marked as a Class IIa medical device under EU MDR and validated according to ISO 81060-2 international standards. Clinical studies have demonstrated that users with high or very high blood pressure were able to reduce systolic readings by up to 7 mmHg after six months of monitoring. The Hilo App provides weekly and monthly blood pressure averages, trend analysis, time-in-target-range metrics, and doctor-ready reports. The system integrates with Apple Health and Health Connect, and includes sleep duration and activity tracking to help users understand lifestyle factors affecting cardiovascular health. Hilo primarily serves consumers managing hypertension and healthcare providers seeking continuous blood pressure data for their patients.
Company description Hilo official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Recorded integration context: Apple Health, Health Connect.
Company milestones
Named Best blood pressure monitoring solution in Europe 2025. Over 120,000 users worldwide using Aktiia-powered technology. 4.7 rating with 1.9k App Store reviews.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
View blood pressure trends, personalized insights and doctor-ready reports
Medical-grade wearable for continuous blood pressure monitoring
Clinically certified cuffless and continuous blood pressure monitoring solution
Upper-arm cuff for initial and periodic calibration
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Proceedings of the National Academy of Sciences of the United States of America · Sep 8, 2026
Machine learning-enabled chemical ecology for integrated pest management: from volatiles to field applications.Journal of insect science (Online) · Sep 1, 2026
Persistent behavioral, biological, and physiological sequelae in active-duty treatment-seeking U.S. special operations forces personnel: a cross-sectional study.Lancet regional health. Americas · Sep 1, 2026
Considerations for Offering an Extended Online Doctor of Pharmacy Program.American journal of pharmaceutical education · Aug 24, 2026
Identifying wastewater pollution hotspots in coastal Hawaiian waters with high freshwater inputs.Marine pollution bulletin · Aug 20, 2026
Discovery of Monoterpenoid Indole Alkaloids Targeting CCN1 to Suppress Autophagy for the Treatment of Hypoxic Kidney Injury.Journal of medicinal chemistry · Aug 18, 2026
Clinical validation
NCT03984448 · Mentioned · ACTIVE NOT RECRUITING
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic LeukemiaNCT03737981 · Mentioned · ACTIVE NOT RECRUITING
Assessing the Ability of Combination Treatment With Venetoclax to Permit Time Limited Therapy in Chronic Lymphocytic LeukemiaNCT03701282 · Mentioned · ACTIVE NOT RECRUITING
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaNCT03150693 · Mentioned · RECRUITING
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD TrialNCT04457596 · Mentioned · ACTIVE NOT RECRUITING
Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With AtezolizumabNCT06771518 · Mentioned · RECRUITING
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
After 6 months of monitoring in users with high or very high blood pressure
Continuous monitoring without user intervention
For both systolic and diastolic readings per ISO 81060-2 validation
Reduction of high blood pressure through continuous monitoring
Up to 7 mmHg reduction in systolic blood pressure after 6 months of monitoring
05 · Leadership
Leadership profiles and professional links from the current Company record.
Dr. Jay Shah
VP MD, FACC
06 · Company updates
Recent articles published on Hilo's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.